5-Bromosalicylic acid → 5-Bromo-N-[3,5-bis[(1,1-dimethyl)ethyl]phenyl)-2-hydroxybenzamide

HRID 421143

반응식

HRID 421143 반응식
[Br:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[CH3:12][C:13]([C:16]1[CH:17]=[C:18]([CH:20]=[C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])[CH:22]=1)[NH2:19])([CH3:15])[CH3:14]>>[CH3:15][C:13]([C:16]1[CH:17]=[C:18]([NH:19][C:7](=[O:9])[C:6]2[CH:10]=[C:2]([Br:1])[CH:3]=[CH:4][C:5]=2[OH:11])[CH:20]=[C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])[CH:22]=1)([CH3:12])[CH3:14]

참가 물질

3

반응물 2

HCID 69725-Bromosalicylic acidHCID 754193,5-Di-tert-butylaniline

생성물 1

HCID 237297945-Bromo-N-[3,5-bis[(1,1-dimethyl)ethyl]phenyl)-2-hydroxybenzamide수율 45.2%

실험 절차

Using 5-bromosalicylic acid and 3,5-bis[(1,1-dimethyl)ethyl]aniline as the raw materials, the same operation as the example 16 gave the title compound.

출처 및 근거

ORD 기록
ord-d52ab960829747e4b3430d770897cdeb
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08097759B2

연결된 노트

불러오는 중…